Patents by Inventor Fintan KEEGAN

Fintan KEEGAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20220071896
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: November 17, 2021
    Publication date: March 10, 2022
    Inventors: Fintan KEEGAN, Robert Gerard BELL, Roger CRYSTAL, Michael Brenner WEISS
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20210093557
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: May 7, 2020
    Publication date: April 1, 2021
    Inventors: Fintan KEEGAN, Robert Gerard BELL, Roger CRYSTAL, Michael Brenner WEISS
  • LOW-TEMPERATURE STABLE OPIOID ANTAGONIST SOLUTIONS
    Publication number: 20200352934
    Abstract: The present invention relates to pharmaceutical compositions comprising an opioid antagonist, PG, and an isotonicity agent. The pharmaceutical compositions are stable at temperatures as low as ?5° C. or lower. Methods of using the pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: September 28, 2018
    Publication date: November 12, 2020
    Inventors: Ryan LOUGHLIN, Fintan KEEGAN, Gerard Robert BELL
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20200030229
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: October 8, 2019
    Publication date: January 30, 2020
    Inventors: Fintan KEEGAN, Robert Gerard BELL, Roger CRYSTAL, Michael Brenner WEISS
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20190015323
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: September 14, 2018
    Publication date: January 17, 2019
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 10085937
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: October 2, 2018
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • LOW-TEMPERATURE STABLE OPIOID ANTAGONIST SOLUTIONS
    Publication number: 20180193332
    Abstract: The present invention relates to pharmaceutical compositions comprising an opioid antagonist, PG, and an isotonicity agent. The pharmaceutical compositions are stable at temperatures as low as ?5° C. or lower. Methods of using the pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: January 8, 2018
    Publication date: July 12, 2018
    Inventors: Ryan Loughlin, Fintan Keegan, Robert Gerard Bell
  • Nasal drug products and methods of their use
    Patent number: 9775838
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: October 3, 2017
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170239241
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: May 8, 2017
    Publication date: August 24, 2017
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 9707226
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: July 18, 2017
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170151230
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: January 25, 2017
    Publication date: June 1, 2017
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170151231
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170071851
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: September 16, 2016
    Publication date: March 16, 2017
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 9561177
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: February 7, 2017
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20160303041
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: June 15, 2016
    Publication date: October 20, 2016
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • METHOD FOR TITRATING CLOZAPINE
    Publication number: 20110172210
    Abstract: Method for titrating clozapine in treatment of psychotic disorders in a human patient in need of treatment with clozapine including administering once-a-day controlled release clozapine to the human patient titrating to a therapeutic dose of clozapine within a period of less than one week, or administering controlled release clozapine to the patient at an initial dose of at least 37.5 mg and titrating to a therapeutic dose within a period of less than ten days.
    Type: Application
    Filed: January 10, 2011
    Publication date: July 14, 2011
    Applicant: AZUR PHARMA LIMITED
    Inventors: Seamus MULLIGAN, Fintan KEEGAN